↓ Skip to main content
What is this page? Embed badge

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

Overview of attention for article published in Oncologist, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
55 Mendeley
Summary News Blogs X Facebook Dimensions citations
So far, Altmetric has seen 1 blog post.

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.